The efficacy of lead shielding in megavoltage radiotherapy.
The dose received by anatomical structures which are apparently shielded by lead blocks during a course of megavoltage radiotherapy may not be negligible. The dose has three main components; there is that due to radiation transmitted through the shielding block, that due to radiation scattered within the patient and that due to radiation scattered prior to reaching the patient and so circumventing the shield. A calculation method which separates the three components has been investigated and the results have been compared with measurements in a wide range of test situations for both cobalt-60 and 6 MV photon beams. The method of calculation predicts the dose behind the shielding block with acceptable accuracy in all the conditions investigated.
Marrs
J E
JE
North Western Medical Physics Department, Christie Hospital, Manchester, UK.
Hounsell
A R
AR
Wilkinson
J M
JM
D003037:Cobalt Radioisotopes; D006801:Humans; D007854:Lead; D011829:Radiation Dosage; D011835:Radiation Protection; D011882:Radiotherapy, High-Energy
D003037:Cobalt Radioisotopes; D007854:Lead